- Question ID
-
2024_6994
- Legal act
- Regulation (EU) No 2019/2033 (IFR)
- Topic
- K-factor requirements
- Article
-
27
- COM Delegated or Implementing Acts/RTS/ITS/GLs/Recommendations
- Not applicable
- Article/Paragraph
-
N/A
- Type of submitter
-
Investment firm
- Subject matter
-
Eligibility of funded credit protection received from third parties
- Question
-
Can cash collateral received from third parties via funded credit protection arrangements (i.e. funded guarantees or credit derivatives) qualify as collateral for the purposes of K-TCD and K-CON?
- Background on the question
-
It is common practice for firms to manage their counterparty credit risk exposures arising from derivatives activity by entering into credit protection arrangements with third parties whereby a firm would receive cash collateral via a funded guarantee or credit derivative. Such cash collateral is used to secure present and future obligations associated with the counterparty credit risk exposure to the derivatives counterparty. The recognition of funded credit protection is particularly critical to groups as it is the primary mechanism for entities of a group to be able to benefit from the capital and liquidity support of third party group entities with access to a greater pool of resources. All funded credit protection (FCP) arrangements are typically accompanied by independent, written and reasoned legal opinions which confirm the effectiveness and enforceability of the protection in relevant jurisdictions, and to provide appropriate certainty as to the credit protection achieved.
Under IFR Art 27, which outlines the calculation of the exposure value for the purposes of computing K-TCD (Trading Counterparty Default), and which serves as a basis for computing the exposure value for K-CON (Concentration Risk) (Art 36), collateral can be used as a mitigant in computing the exposure value. However, it is not clear whether the meaning of collateral in Art 27 encompasses both (i) collateral received directly from the counterparty via a margin agreement and (ii) collateral received from a third party via an FCP arrangement.
IFR Art 27 states that “Collateral”, as determined in IFR Art 30 can be deducted when calculating an exposure value for transactions subject to trading counterparty default. According to IFR Art 30(1), all collateral for both bilateral and cleared transactions referred to in Art 25 shall be subject to volatility adjustments. However, IFR Art 30(2), which specifically details how collateral should be valued, appears to apply only to collateral received from the counterparty to the transaction:
“2. The value of collateral shall be determined as follows:
(a) for the purposes of points (a), (e) and (g) of Article 25(1), by the amount of collateral received by the investment firm from its counterparty decreased in accordance with Table 4;
(b) for the transactions referred to in points (b), (c), (d) and (f) of Article 25(1), by the sum of the CMV of the security leg and the net amount of collateral posted or received by the investment firm […].”
It is therefore not clear whether the purpose of Art 30 is intended to apply only to collateral received from the transaction counterparty.
- Submission date
- Final publishing date
-
- Final answer
-
Article 27 of the IFR states that the amount of “collateral”, as determined in Article 30, can be deducted when calculating an exposure value for transactions subject to K-TCD and K-CON.
In turn, Article 30(1) determines that all collateral for both bilateral and cleared transactions referred to in Article 25 shall be subject to the volatility adjustments established in Table 4 of Article 30(1). It can be considered that the latter is setting out the asset classes that are eligible as collateral under the IFR.
However, Article 30(2), which specifically details how collateral should be valued, appears to apply only to collateral received from the direct counterparty to the transaction. This specification in Article 30(2) therefore raises the question whether it was intended to only permit collateral received directly from the counterparty to the transaction to be eligible when calculating an exposure value for transactions subject to K-TCD and K-CON or whether collateral received from third parties (i.e. protection providers) through funded credit protections would also be eligible.
Although Article 30(2), point (a), only refers to the amount of collateral received by the investment firm from its counterparty, it cannot be inferred from this that collateral received from a protection provider would not be eligible for the calculation of the exposure value under Article 27.
For determining whether collateral received from a protection provider would be eligible, the investment firm should obtain the legal certainty that it will be promptly transferred the property of the collateral in the case of default of the direct counterparty or that the pledged collateral will remain available in the case of default of the protection provider.
In principle, funded credit protections provided by third parties, whereby cash or securities are pledged in the name of the investment firm, which are available at first demand and without any restriction in the case of default of the direct counterparty could also be accepted as collateral under the IFR.
However, the IFR does not specify the eligibility criteria of a funded credit protection as collateral. For this assessment, investment firms could refer to the requirements set out in Regulation (EU) No 575/2013 (Capital Requirements Regulation or “CRR”), such as Article 212(1), as guidelines. On their side, competent authorities will assess the eligibility and the quality of this collateral as part of their Supervisory Review and Evaluation Process (SREP) and will consider whether any residual risk needs to be addressed through Pillar 2.
In this context, it is useful to note that unfunded credit protections and credit derivatives, or any other type of derivatives, received from counterparties, or third parties, are not eligible as collateral under the IFR. These instruments were not considered to be permissible by the legislator and therefore not listed in Table 4 of Article 30(1) of the IFR.
Disclaimer:
The answer clarifies provisions already contained in the applicable legislation. It does not extend in any way the rights and obligations deriving from such legislation; nor does it introduce any additional requirements for the concerned operators and competent authorities. The answer is merely intended to assist natural or legal persons; including competent authorities and Union institutions and bodies in clarifying the application or implementation of the relevant legal provisions. Only the Court of Justice of the European Union is competent to authoritatively interpret Union law. The views expressed in the internal Commission Decision cannot prejudge the position that the European Commission might take before the Union and national courts.
- Status
-
Final Q&A
- Answer prepared by
-
Answer prepared by the European Commission because it is a matter of interpretation of Union law.
Disclaimer
The Q&A refers to the provisions in force on the day of their publication. The EBA does not systematically review published Q&As following the amendment of legislative acts. Users of the Q&A tool should therefore check the date of publication of the Q&A and whether the provisions referred to in the answer remain the same.